Lysosomal enzyme-cleavable antitumor drug conjugates
US6214345A · kind A · utility
621Cited by
15References
258Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 1993 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | May 14, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to drug-ligand conjugates wherein the drug is linked to the ligand through a protein peptide linker and a connector, a process for the preparation of the conjugates, method of controlling the growth of undesirable cells, pharmaceutical compositions, and intermediates thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.